Pharmacy News

Subscribe to Pharmacy News feed
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Updated: 50 min 18 sec ago

Final chance to enter into the 2019 Sales Awards!

11/09/2019
The 2019 PharmaTimes Sales Awards will be closing for entry on Friday – this is the last chance for sales professionals to enter.

Cassava’s lead Alzheimer’s candidate hits endpoints

10/09/2019
The new treatment could be an "important part of the research dialogue in Alzheimer’s disease.”

Bayer’s two-year data confirms Eylea effectiveness

10/09/2019
Wet AMD is a serious and debilitating sight-threatening condition that requires ongoing treatment to prevent worsening.

Spravato reduces depressive symptoms in 24 hours

10/09/2019
Both studies showed clinically meaningful and statistically significant superiority of the drug.

PRAC to review Picato skin cancer data

10/09/2019
The committee will now carry out a thorough review of all available data, including from ongoing studies.

NHS to review making statins available for pharmacists

09/09/2019
If only 45% of people with a high risk of cardiovascular disease were identified and treated, 6,000 strokes and heart attacks could be avoided over the next ten years.

Novartis confirms long-term efficacy, safety of Aimovig

09/09/2019
Back in April the SMC accepted the drug for use in patients with chronic migraine.

EQL accepted by NHS accelerator programme

09/09/2019
Earlier this year, EQL launched its debut product ‘Phio’, a chatbot that thinks and acts like a physiotherapist.

NHS to roll out high street heart checks

09/09/2019
Cardiovascular disease costs the NHS £7 billion a year.

Imfinzi shows survival benefit in aggressive lung cancer

09/09/2019
The drug cut the risk of death by 27%.

Only 1 week left to enter into the 2019 Sales Awards!

06/09/2019
There is now only 1 week left to secure your place in the 2019 Sales Awards, which will be closing for entry on Friday the 13th of September.

EU Marketing Authorisation granted for Lonsurf

06/09/2019
The approval is a “landmark decision for patients across the European Union."

LIVI partners with Boots

06/09/2019
The NHS Long Term Plan states that all patients should have access to online and video consultations by 2021.

EU approval for Tecentriq-based NSCLC combo

06/09/2019
The drug is a monoclonal antibody designed to bind with a protein called PD-L1.

Keytruda combo bags EU approval in RCC

06/09/2019
The combo reduced the risk of death by 47% in a clinical trial.

Spending Round provides ‘much-needed’ NHS funding

05/09/2019
The NHS will recieve a cash increase of £33.9 billion a year by 2023-24 compared to 2018-19 budgets.

AstraZeneca, Theranostics sign PARPi development agreement

05/09/2019
The licensing agreement enables the company’s “freedom to operate globally in the diagnostic field of certain selected radionuclide-labelled PARPi.”

Snack tax could be ‘more effective’ than sugary drink tax

05/09/2019
The news comes after Cancer Research UK found that obesity causes more cases of certain cancers than smoking.

Breakthrough Designation granted for Janssen’s RSV vaccine

05/09/2019
RSV is a highly prevalent, very contagious respiratory infection and a leading cause of bronchitis and pneumonia.

J&J launches ‘Make Blood Cancer Visible’ campaign

05/09/2019
The company has released a short documentary and five mini-films, outlining the symptoms that led patients to their diagnosis.

Pages

X